Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06654050
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-22
Brief Title:
Alrizomadlin APG-115 in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma
Sponsor:
None
Organization:
None
Conditions & Keywords Data
Conditions:
Keywords: